🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, cross-over, fixed-sequence study. All subjects will ...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02473627
Treatments Being Tested
This study is an open-label drug-drug interaction (DDI) study of ZYN002 tra...
Status
Completed
Location
CMAX Clinical Research
Start Date
2025-06-06
Trial ID
NCT06930872
The study is being conducted to assess the effect of BMS-986142 on the sing...
Status
Completed
Location
Ppd Development, Lp
Start Date
2016-05
Trial ID
NCT02762123
PEGASUS aims to test acceptability and feasibility of studying phenoconvers...
Status
Recruiting
Location
Peter MacCallum Cancer Centre
Start Date
2025-07-22
Trial ID
NCT06383338
Treatments Being Tested
This study will evaluate the effects of nirogacestat 100 mg twice daily (BI...
Status
Completed
Location
ICON Martini Groningen CRU
Start Date
2025-10-27
Trial ID
NCT07259330
Treatments Being Tested
The goal of this observational study aims to reveal the pharmacokinetics of...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2023-03-28
Trial ID
NCT05893849
Treatments Being Tested
This is a Phase 1, open-label, 3-period study to determine radiprodil's pot...
Status
Completed
Location
Nucleus Network Melbourne
Start Date
2025-05-20
Trial ID
NCT06975605
Treatments Being Tested
CYP2C19 is responsible for the metabolism of approximately 10% of drugs cur...
Status
Unknown
Location
Geneva University Hospitals, HUG
Start Date
2022-04-01
Trial ID
NCT05264142
Treatments Being Tested
The main purpose of this study is to determine the potential inhibitory/ind...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2017-03-14
Trial ID
NCT03058419
This is a Phase 1, open-label, two-part, safety, PK, and activity study des...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2017-03-27
Trial ID
NCT03028103
Treatments Being Tested